Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$650M |
| 2 |
Apple
AAPL
|
+$468M |
| 3 |
Marvell Technology
MRVL
|
+$458M |
| 4 |
Chevron
CVX
|
+$410M |
| 5 |
WIX.com
WIX
|
+$392M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$836M |
| 2 |
Bloom Energy
BE
|
+$727M |
| 3 |
Accenture
ACN
|
+$563M |
| 4 |
Broadcom
AVGO
|
+$549M |
| 5 |
Lam Research
LRCX
|
+$543M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.76% |
| 2 | Financials | 11.48% |
| 3 | Industrials | 8.17% |
| 4 | Healthcare | 7.37% |
| 5 | Consumer Discretionary | 7.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Teva Pharmaceuticals
TEVA
$40.8B
| $2.66M | ﹤0.01% |
131,624
-116,344
| -47% | -$2.04M |
|
2802
AB InBev
BUD
$170B
| $2.66M | ﹤0.01% |
44,550
-19,424
| -30% | -$1.22M |
|
2803
Upbound Group
UPBD
$1.13B
| $2.65M | ﹤0.01% |
112,197
-7,349
| -6% | -$181K |
|
2804
Takeda Pharmaceutical
TAK
$54.6B
| $2.65M | ﹤0.01% |
181,331
-82,761
| -31% | -$1.23M |
|
2805
Janus Henderson Mortgage-Backed Securities ETF
JMBS
$6.68B
| $2.64M | ﹤0.01% |
+57,825
| New | +$2.61M |
|
2806
National Presto Industries
NPK
$870M
| $2.64M | ﹤0.01% |
23,519
-4,671
| -17% | -$496K |
|
2807
Ampco-Pittsburgh
AP
$163M
| $2.64M | ﹤0.01% |
1,151,665
-8,016
| -0.7% | -$23.8K |
|
2808
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.89B
| $2.63M | ﹤0.01% |
42,997
-4,982
| -10% | -$296K |
|
2809
Helix Energy Solutions
HLX
$1.4B
| $2.63M | ﹤0.01% |
400,303
-15,447
| -4% | -$97.2K |
|
2810
Canadian Imperial Bank of Commerce
CM
$108B
| $2.62M | ﹤0.01% |
25,451
-586
| -2% | -$44.1K |
|
2811
Insperity
NSP
$1.93B
| $2.62M | ﹤0.01% |
53,284
-13,983
| -21% | -$766K |
|
2812
Mesa Laboratories
MLAB
$564M
| $2.62M | ﹤0.01% |
39,095
-34,418
| -47% | -$2.48M |
|
|
CNTA
2813
DELISTED
Centessa Pharmaceuticals
CNTA
| $2.62M | ﹤0.01% |
+108,002
| New | +$1.92M |
|
2814
Valens Semiconductor
VLN
$170M
| $2.61M | ﹤0.01% |
1,460,542
-12,400
| -0.8% | -$28K |
|
2815
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
| $2.61M | ﹤0.01% |
115,829
-8,505
| -7% | -$189K |
|
2816
Choice Hotels
CHH
$5.07B
| $2.6M | ﹤0.01% |
24,339
-1,500
| -6% | -$183K |
|
2817
Harmony Biosciences
HRMY
$2.04B
| $2.59M | ﹤0.01% |
94,148
+1,542
| +2% | +$53.1K |
|
|
LENZ
2818
LENZ Therapeutics
LENZ
$166M
| $2.59M | ﹤0.01% |
55,673
+1,730
| +3% | +$63.6K |
|
2819
CBIZ
CBZ
$2.99B
| $2.59M | ﹤0.01% |
48,819
-95,471
| -66% | -$6.16M |
|
2820
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$269M
| $2.58M | ﹤0.01% |
37,804
-1,691
| -4% | -$113K |
|
2821
Invesco Mortgage Capital
IVR
$759M
| $2.58M | ﹤0.01% |
340,898
+4,101
| +1% | +$31.3K |
|
2822
A10 Networks
ATEN
$2.13B
| $2.58M | ﹤0.01% |
141,971
-6,667
| -4% | -$121K |
|
|
ZEUS
2823
DELISTED
Olympic Steel
ZEUS
| $2.58M | ﹤0.01% |
84,601
+30,903
| +58% | +$1.01M |
|
2824
World Acceptance Corp
WRLD
$838M
| $2.57M | ﹤0.01% |
15,224
-400
| -3% | -$67.3K |
|
2825
Collegium Pharmaceutical
COLL
$1.15B
| $2.57M | ﹤0.01% |
73,552
-3,073
| -4% | -$107K |
|
Similar funds
Ameriprise's Q3 2025 Portfolio in Review
As of Q3 2025, Ameriprise held 4,210 positions worth $435B, up 7.3% from $406B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Ameriprise's Q3 2025 filing shows 266 new, 1,586 increased, 2,101 reduced and 160 closed positions. Its largest new stake was Aptiv: 3,450,314 shares worth $298M. The largest sale was Microsoft, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.
- Ameriprise's largest Q3 2025 buy was Aptiv: 3,450,314 shares worth $298M.
- Ameriprise added most to Applied Materials in Q3 2025, an estimated $650M increase.
- Ameriprise's biggest Q3 2025 reduction was Microsoft, cutting an estimated $836M.
- Ameriprise fully exited Hess in Q3 2025, selling an estimated $77.2M.
- Ameriprise's ten largest holdings make up 22% of its $435B portfolio in Q3 2025.
- Ameriprise opened 266 new positions and closed 160 in Q3 2025.
- Ameriprise's portfolio value rose 7.3% quarter-over-quarter to $435B.
Based on Ameriprise's 13F filing for Q3 2025, filed 14 Nov 2025.